146 related articles for article (PubMed ID: 33933552)
21. A20 (TNFAIP3) Alterations in Primary Intestinal Diffuse Large B-cell Lymphoma.
Fujii M; Takata K; Chuang SS; Miyata-Takata T; Ando M; Sato Y; Yoshino T
Acta Med Okayama; 2018 Feb; 72(1):23-30. PubMed ID: 29463935
[TBL] [Abstract][Full Text] [Related]
22. Di-(2-ethylhexyl) phthalate suppresses IL-12p40 production by GM-CSF-dependent macrophages via the PPARα/TNFAIP3/TRAF6 axis after lipopolysaccharide stimulation.
Yamaguchi R; Sakamoto A; Yamamoto T; Narahara S; Sugiuchi H; Hisada A; Katoh T; Yamaguchi Y
Hum Exp Toxicol; 2018 Jun; 37(6):596-607. PubMed ID: 28673093
[TBL] [Abstract][Full Text] [Related]
23. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
24. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
25. A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes.
Feoktistova M; Makarov R; Brenji S; Schneider AT; Hooiveld GJ; Luedde T; Leverkus M; Yazdi AS; Panayotova-Dimitrova D
Cells; 2020 Feb; 9(2):. PubMed ID: 32028675
[TBL] [Abstract][Full Text] [Related]
26. miR-200a enhances TRAIL-induced apoptosis in gastric cancer cells by targeting A20.
Guo T; Zhang Y; Qu X; Che X; Li C; Fan Y; Wan X; Ma R; Hou K; Zhou H; He X; Hu X; Liu Y; Xu L
Cell Biol Int; 2018 May; 42(5):506-514. PubMed ID: 29274253
[TBL] [Abstract][Full Text] [Related]
27. Preserving immune homeostasis with A20.
Razani B; Malynn BA; Ma A
Adv Immunol; 2020; 148():1-48. PubMed ID: 33190732
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression.
Sasse SK; Altonsy MO; Kadiyala V; Cao G; Panettieri RA; Gerber AN
Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L421-32. PubMed ID: 27371733
[TBL] [Abstract][Full Text] [Related]
29. [Immune regulation role of A20 and its clinical significance].
Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
[TBL] [Abstract][Full Text] [Related]
30. Targeting A20 decreases glioma stem cell survival and tumor growth.
Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
[TBL] [Abstract][Full Text] [Related]
31. Intracelluar delivery of A20 protein inhibits TNFα-induced NF-κB activation.
Lee HR; Choi J; Lee SH; Cho ML; Jue DM
Protein Expr Purif; 2018 Mar; 143():14-19. PubMed ID: 28988144
[TBL] [Abstract][Full Text] [Related]
32. Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3.
He T; Huang Y; Luo Y; Xia Y; Wang L; Zhang H; Ling J; Yang J
J Clin Immunol; 2020 Jul; 40(5):741-751. PubMed ID: 32514655
[TBL] [Abstract][Full Text] [Related]
33. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
[TBL] [Abstract][Full Text] [Related]
34. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
[TBL] [Abstract][Full Text] [Related]
35. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme.
Malynn BA; Ma A
J Exp Med; 2009 May; 206(5):977-80. PubMed ID: 19380636
[TBL] [Abstract][Full Text] [Related]
36. miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis.
Xiao FJ; Zhang D; Wu Y; Jia QH; Zhang L; Li YX; Yang YF; Wang H; Wu CT; Wang LS
Biochem Biophys Res Commun; 2019 Jul; 515(3):448-454. PubMed ID: 31160087
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells.
Yin L; Fang Z; Shen NJ; Qiu YH; Li AJ; Zhang YJ
Drug Des Devel Ther; 2017; 11():2841-2850. PubMed ID: 29033545
[TBL] [Abstract][Full Text] [Related]
38. DNGR1-Cre-mediated Deletion of
Koudstaal T; van Hulst JAC; Das T; Neys SFH; Merkus D; Bergen IM; de Raaf MA; Bogaard HJ; Boon L; van Loo G; Aerts JGJV; Boomars KA; Kool M; Hendriks RW
Am J Respir Cell Mol Biol; 2020 Nov; 63(5):665-680. PubMed ID: 32755457
[TBL] [Abstract][Full Text] [Related]
39. High A20 expression negatively impacts survival in patients with breast cancer.
Yoon CI; Ahn SG; Bae SJ; Shin YJ; Cha C; Park SE; Lee JH; Ooshima A; Lee HS; Yang KM; Kim SJ; Park SH; Jeong J
PLoS One; 2019; 14(8):e0221721. PubMed ID: 31449546
[TBL] [Abstract][Full Text] [Related]
40. A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator.
Bhattacharyya S; Wang W; Graham LV; Varga J
Arthritis Res Ther; 2016 Oct; 18(1):216. PubMed ID: 27716397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
